Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency, Chronic | 5 | 2017 | 97 | 1.310 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 5 | 2019 | 41 | 0.760 |
Why?
|
| Kidney Failure, Chronic | 3 | 2019 | 161 | 0.760 |
Why?
|
| Kidney Transplantation | 2 | 2021 | 125 | 0.670 |
Why?
|
| Nephrology | 1 | 2016 | 14 | 0.560 |
Why?
|
| Podocytes | 6 | 2019 | 85 | 0.550 |
Why?
|
| Referral and Consultation | 1 | 2016 | 86 | 0.530 |
Why?
|
| Proteinuria | 4 | 2019 | 81 | 0.480 |
Why?
|
| Malnutrition | 1 | 2014 | 20 | 0.470 |
Why?
|
| Dyslipidemias | 1 | 2014 | 23 | 0.470 |
Why?
|
| Integrin alphaVbeta3 | 2 | 2019 | 21 | 0.320 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 2 | 2017 | 44 | 0.290 |
Why?
|
| Kidney | 3 | 2021 | 173 | 0.250 |
Why?
|
| Kidney Diseases | 2 | 2019 | 115 | 0.240 |
Why?
|
| Glomerular Filtration Rate | 3 | 2019 | 59 | 0.230 |
Why?
|
| Needles | 1 | 2021 | 18 | 0.190 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2021 | 21 | 0.190 |
Why?
|
| Inducible T-Cell Co-Stimulator Ligand | 1 | 2019 | 6 | 0.170 |
Why?
|
| Apolipoproteins | 1 | 2017 | 9 | 0.150 |
Why?
|
| Lipoproteins, HDL | 1 | 2017 | 28 | 0.150 |
Why?
|
| Animals | 8 | 2019 | 4577 | 0.150 |
Why?
|
| Myeloid Cells | 1 | 2016 | 16 | 0.150 |
Why?
|
| Humans | 12 | 2021 | 29361 | 0.140 |
Why?
|
| Renal Replacement Therapy | 1 | 2016 | 24 | 0.140 |
Why?
|
| Diabetes Mellitus | 1 | 2017 | 137 | 0.140 |
Why?
|
| Mice | 5 | 2019 | 1620 | 0.130 |
Why?
|
| Cathepsin L | 2 | 2011 | 9 | 0.120 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 63 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 1 | 2011 | 21 | 0.100 |
Why?
|
| Inflammation | 1 | 2014 | 345 | 0.100 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 250 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2011 | 76 | 0.100 |
Why?
|
| Mice, Knockout | 3 | 2019 | 304 | 0.100 |
Why?
|
| Signal Transduction | 3 | 2019 | 483 | 0.090 |
Why?
|
| Kidney Glomerulus | 2 | 2017 | 54 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2019 | 70 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 726 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2021 | 1939 | 0.060 |
Why?
|
| Adult | 3 | 2021 | 8604 | 0.050 |
Why?
|
| Middle Aged | 3 | 2021 | 9823 | 0.050 |
Why?
|
| Transplant Recipients | 1 | 2021 | 23 | 0.050 |
Why?
|
| Pancreas | 1 | 2021 | 32 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2021 | 3273 | 0.050 |
Why?
|
| Biopsy, Needle | 1 | 2021 | 101 | 0.050 |
Why?
|
| Equipment Design | 1 | 2021 | 185 | 0.050 |
Why?
|
| Receptor, PAR-2 | 1 | 2019 | 3 | 0.040 |
Why?
|
| Protein Domains | 1 | 2019 | 10 | 0.040 |
Why?
|
| Adipocytes | 1 | 2019 | 11 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2019 | 16 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2019 | 18 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2019 | 70 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2019 | 53 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 264 | 0.040 |
Why?
|
| Male | 3 | 2021 | 15637 | 0.040 |
Why?
|
| Incidence | 1 | 2021 | 756 | 0.040 |
Why?
|
| Biopsy | 1 | 2019 | 234 | 0.040 |
Why?
|
| Female | 3 | 2021 | 16211 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 788 | 0.040 |
Why?
|
| Apolipoprotein L1 | 1 | 2017 | 8 | 0.040 |
Why?
|
| Surface Plasmon Resonance | 1 | 2017 | 7 | 0.040 |
Why?
|
| Integrins | 1 | 2017 | 19 | 0.040 |
Why?
|
| Albuminuria | 1 | 2017 | 21 | 0.040 |
Why?
|
| Diabetic Nephropathies | 1 | 2017 | 27 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2016 | 55 | 0.040 |
Why?
|
| Alleles | 1 | 2017 | 224 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 57 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2016 | 44 | 0.040 |
Why?
|
| Genotype | 1 | 2017 | 405 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 1812 | 0.030 |
Why?
|
| Aged | 2 | 2021 | 9447 | 0.030 |
Why?
|
| Models, Biological | 1 | 2017 | 344 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 441 | 0.030 |
Why?
|
| Hypertension | 1 | 2017 | 266 | 0.030 |
Why?
|
| Disease Progression | 1 | 2017 | 788 | 0.030 |
Why?
|
| Biomarkers | 1 | 2017 | 692 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2021 | 3476 | 0.030 |
Why?
|
| Peptide Hydrolases | 1 | 2011 | 13 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2011 | 31 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2011 | 51 | 0.030 |
Why?
|
| Cell Survival | 1 | 2011 | 169 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 2280 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 1935 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2011 | 323 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 173 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2011 | 676 | 0.020 |
Why?
|